Business
BIOEX: Operating losses narrowed and liquidity improved, supported by new licensing deals and capital raises
BIOEX: Operating losses narrowed and liquidity improved, supported by new licensing deals and capital raises
About this update from Bioextrax Ab
Net sales and licensing income declined year-over-year, but operating losses narrowed and cash flow improved. Major licensing deals and two rights issues strengthened liquidity, supporting ongoing commercialization and R&D.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.